factually
Index/Topics/GLP-1 RAs vs SGLT-2 inhibitors

GLP-1 RAs vs SGLT-2 inhibitors

Comparison of GLP-1 RAs and SGLT-2 inhibitors in reducing cardiovascular and kidney risk in people with type 2 diabetes

Fact-Checks

1 result
Jan 17, 2026
Most Viewed

How do GLP‑1 receptor agonists and SGLT‑2 inhibitors compare for cardiovascular and renal protection in type 2 diabetes?

Both GLP‑1 receptor agonists (GLP‑1 RAs) and SGLT‑2 inhibitors reduce cardiovascular and kidney risk in people with type 2 diabetes, but they do so with different strengths: GLP‑1 RAs show consistent ...